Abstract: A pharmaceutical composition comprising: (a) an anticholinergic of formula 1 wherein X? is an anion with a single negative charge; (b) a corticosteroid; and (c) a betamimetic, wherein each component (a), (b), and (c) are optionally in the form of the solvates or hydrates thereof, processes for preparing them, and their use in the treatment of respiratory diseases.

Abstract: The present invention relates to a turbocharger assembly lock comprising a retaining ring partially disposed in a circumferential groove of a first turbocharger stage component and partially in a circumferential groove of a second turbocharger stage component so that the turbocharger stages are securely attached to each other.

Abstract: The present invention relates to a turbocharger compressor diffuser loading plate that is in contact with a vaned diffuser and that is in communication with the compressor volute. The diffuser loading plate is pressure loaded so that it moves axially in response to pressure thereby maintaining an effective seal of the open side of the vaned diffuser. The present invention minimizes a loss in compressor performance caused by movement of the compressor housing.

Abstract: A turbocharger includes a compressor housing and a turbine housing wherein at least one of the compressor housing and the turbine housing includes an anti-ballistic material such as, for example, aramid fibers, S glass fibers and/or carbon fibers. A turbocharger system optionally includes a temperature controller that controls temperature in instances where operational temperatures may be detrimental to the performance characteristics of anti-ballistic material. Various other exemplary devices, methods, systems, etc., are also disclosed.

Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and soluble TNF receptor fusion proteins, processes for preparing them and their use in the treatment of respiratory diseases.

Abstract: The invention relates to the use of pteridines for the treatment of inflammatory and obstructive respiratory complaints, preferably asthma or COPD, as well as pharmaceutical compositions containing these compounds.

Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics of the formula 1; wherein X?, R1 ? and Ar are defined as in claim 1, and a heterocyclic compound of the formula 2. Furthermore, the invention relates to processes for preparing them and their use in the treatment of respiratory complaints.

Abstract: A pharmaceutical composition comprising: (a) a salt of formula 1 wherein: X? is an anion with a single negative charge; and (b) a steroid 2, processes for preparing such pharmaceutical composition, and their use in the treatment of respiratory complaints.

Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergies and anti-TNF antibodies, processes for preparing them and their use in the treatment of respiratory diseases.

Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and TNF-alpha-antagonists, processes for preparing them and their use in the treatment of respiratory diseases.

Abstract: An exemplary center housing for a turbocharger includes a lubricant control valve that includes a stem seated at least partially in the center housing where the stem has one or more orifices for controlling lubricant flow. The exemplary center housing also includes a lubricant filter positioned adjacent the stem of the lubricant control valve. The lubricant filter is optionally replaceable, for example, being accessible by removal of the stem from the center housing. Various other exemplary devices, assemblies, systems, methods, etc., are also disclosed.

Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and pegsunercept, processes for preparing them and their use in the treatment of respiratory diseases.

Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and TACE (TNF alpha converting enzyme) inhibitors, processes for preparing them and their use in the treatment of respiratory diseases.

Abstract: A turbocharger includes compressor and/or turbine end housing(s) and removable compressor and/or turbine shroud portion(s) configured in relation to the compressor and/or turbine wheel(s) such that either or both of the wheels can be removed, after removal of the respective shroud portion(s), without having to remove the respective end housing(s). Additionally or alternatively, a turbocharger includes removable and replaceable compressor and/or turbine seal(s) supported by removable compressor and/or turbine seal plate(s).

Abstract: An exemplary center housing for a turbocharger includes a filter well for receiving a lubricant filter unit. An exemplary filter unit, for attachment to a center housing of a turbocharger, includes an attachment mechanism to attach the filter unit to the center housing, a filter for filtering lubricant and a lubricant flow path where the lubricant flow path commences at a peripheral surface of the filter unit, passes through the filter and ends at a bore surface of the filter unit. Various other exemplary devices, assemblies, systems, methods, etc., are also disclosed.

Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics, processes for preparing them and their use in the treatment of respiratory diseases.

Abstract: The present invention relates to novel pharmaceutical compositions based on fluorene carboxylic acid ester derived anticholinergics of formula 1 and soluble TNF receptor fusion proteins, processes for preparing them and their use in the treatment of respiratory diseases.

Abstract: The present invention relates to novel pharmaceutical compositions based on benzilic acid ester derived anticholinergics of formula 1 and soluble TNF receptor fusion proteins, processes for preparing them and their use in the treatment of respiratory diseases.

Abstract: The present invention relates to novel pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors, processes for preparing them and their use in the treatment of respiratory diseases.

Abstract: The invention relates to the use of pteridines for the treatment of inflammatory and obstructive respiratory complaints, preferably asthma or COPD, as well as pharmaceutical compositions containing these compounds.